Santen Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	552,471	484,047	559,190	424,342	490,898	608,810
Market Cap Growth	5.37%	-13.44%	31.78%	-13.56%	-19.37%	-17.96%
Enterprise Value	489,981	405,379	476,424	362,459	422,435	555,406
Last Close Price	1717.50	1401.52	1484.82	1067.53	1124.04	1364.10
PE Ratio	18.70	13.35	21.00	-	18.04	89.19
Forward PE	15.05	14.12	17.09	25.03	16.26	21.32
PS Ratio	1.92	1.61	1.85	1.52	1.84	2.44
PB Ratio	1.96	1.70	1.83	1.45	1.46	1.98
P/TBV Ratio	2.68	2.30	2.52	2.15	2.37	3.13
P/FCF Ratio	15.55	8.92	8.83	21.36	17.11	17.56
P/OCF Ratio	13.34	7.95	7.70	11.42	10.66	15.69
PEG Ratio	1.92	2.79	2.79	2.79	2.79	3.56
EV/Sales Ratio	1.70	1.35	1.58	1.30	1.59	2.23
EV/EBITDA Ratio	8.19	6.12	6.77	6.90	7.98	7.90
EV/EBIT Ratio	11.77	8.39	9.13	10.27	11.78	10.38
EV/FCF Ratio	13.79	7.47	7.52	18.24	14.72	16.02
Debt / Equity Ratio	-	0.12	0.11	0.12	0.10	0.03
Debt / EBITDA Ratio	-	0.52	0.49	0.69	0.62	0.14
Debt / FCF Ratio	-	0.63	0.55	1.82	1.15	0.29
Net Debt / Equity Ratio	-0.22	-0.21	-0.20	-0.07	-0.15	-0.17
Net Debt / EBITDA Ratio	-1.02	-0.89	-0.85	-0.41	-0.95	-0.75
Net Debt / FCF Ratio	-1.73	-1.08	-0.95	-1.09	-1.74	-1.52
Asset Turnover	0.72	0.71	0.71	0.63	0.62	0.62
Inventory Turnover	2.26	2.72	2.99	2.95	2.79	2.56
Quick Ratio	1.73	1.90	2.00	1.85	1.91	2.02
Current Ratio	2.68	2.58	2.55	2.38	2.39	2.63
Return on Equity (ROE)	10.79%	12.14%	8.92%	-4.75%	8.45%	2.18%
Return on Assets (ROA)	6.46%	7.14%	7.61%	5.01%	5.20%	8.25%
Return on Invested Capital (ROIC)	14.88%	15.46%	18.05%	12.64%	10.12%	11.99%
Return on Capital Employed (ROCE)	13.00%	15.00%	15.20%	10.60%	9.90%	16.50%
Earnings Yield	5.54%	7.49%	4.76%	-3.52%	5.54%	1.12%
FCF Yield	6.43%	11.21%	11.33%	4.68%	5.85%	5.70%
Dividend Yield	2.20%	2.57%	2.22%	3.00%	2.85%	2.05%
Payout Ratio	41.30%	33.40%	44.59%	-	44.07%	163.81%
Buyback Yield / Dilution	6.20%	5.01%	4.98%	3.26%	-0.02%	-0.03%
Total Shareholder Return	8.40%	7.58%	7.20%	6.25%	2.83%	2.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.